Form 8-K - Current report:
SEC Accession No. 0001104659-25-008615
Filing Date
2025-02-03
Accepted
2025-02-03 16:05:31
Documents
17
Period of Report
2025-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255124d1_8k.htm   iXBRL 8-K 27465
2 EXHIBIT 10.1 tm255124d1_ex10-1.htm EX-10.1 47510
3 GRAPHIC tm255124d1_ex10-2img001.jpg GRAPHIC 274375
4 GRAPHIC tm255124d1_ex10-2img002.jpg GRAPHIC 222277
5 GRAPHIC tm255124d1_ex10-2img003.jpg GRAPHIC 173682
  Complete submission text file 0001104659-25-008615.txt   1185204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA trvn-20250131.xsd EX-101.SCH 3021
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20250131_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20250131_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT tm255124d1_8k_htm.xml XML 3567
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 25582498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)